MetLife Investment Management’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.11M | Buy |
26,636
+666
| +3% | +$26.8K | 0.01% | 1475 |
|
|
2026
Q1 | $867K | Buy |
25,970
+378
| +1% | +$15.8K | ﹤0.01% | 1470 |
|
|
2025
Q4 | $1.16M | Sell |
25,592
-1,822
| -7% | -$66.7K | 0.01% | 1340 |
|
|
2025
Q3 | $835K | Hold |
27,414
| – | – | ﹤0.01% | 1560 |
|
|
2025
Q2 | $806K | Hold |
27,414
| – | – | ﹤0.01% | 1425 |
|
|
2025
Q1 | $958K | Sell |
27,414
-407
| -1% | -$16.1K | 0.01% | 1395 |
|
|
2024
Q4 | $1.24M | Buy |
27,821
+1,541
| +6% | +$69.2K | 0.01% | 1308 |
|
|
2024
Q3 | $1.15M | Sell |
26,280
-814
| -3% | -$30.7K | 0.01% | 1317 |
|
|
2024
Q2 | $733K | Buy |
27,094
+3,557
| +15% | +$103K | ﹤0.01% | 1514 |
|
|
2024
Q1 | $688K | Hold |
23,537
| – | – | ﹤0.01% | 1508 |
|
|
2023
Q4 | $886K | Hold |
23,537
| – | – | 0.01% | 1365 |
|
|
2023
Q3 | $1.06M | Sell |
23,537
-26,123
| -53% | -$1.58M | 0.01% | 1196 |
|
|
2023
Q2 | $3.66M | Buy |
49,660
+37
| +0.1% | +$2.5K | 0.03% | 647 |
|
|
2023
Q1 | $2.91M | Sell |
49,623
-734
| -1% | -$40.5K | 0.02% | 757 |
|
|
2022
Q4 | $2.54M | Sell |
50,357
-345
| -0.7% | -$20.7K | 0.02% | 799 |
|
|
2022
Q3 | $4.41M | Buy |
50,702
+27,533
| +119% | +$2.89M | 0.04% | 474 |
|
|
2022
Q2 | $2.64M | Hold |
23,169
| – | – | 0.02% | 780 |
|
|
2022
Q1 | $3M | Buy |
23,169
+8,257
| +55% | +$1.19M | 0.02% | 815 |
|
|
2021
Q4 | $2.69M | Hold |
14,912
| – | – | 0.02% | 730 |
|
|
2021
Q3 | $2.21M | Sell |
14,912
-885
| -6% | -$136K | 0.02% | 816 |
|
|
2021
Q2 | $2.39M | Hold |
15,797
| – | – | 0.02% | 799 |
|
|
2021
Q1 | $2.05M | Sell |
15,797
-902
| -5% | -$116K | 0.02% | 860 |
|
|
2020
Q4 | $2M | Sell |
16,699
-931
| -5% | -$91.3K | 0.02% | 821 |
|
|
2020
Q3 | $1.32M | Sell |
17,630
-1,147
| -6% | -$79.5K | 0.01% | 913 |
|
|
2020
Q2 | $1.33M | Buy |
18,777
+1,458
| +8% | +$99.8K | 0.02% | 912 |
|
|
2020
Q1 | $1.14M | Sell |
17,319
-1,023
| -6% | -$81.5K | 0.02% | 849 |
|
|
2019
Q4 | $1.5M | Hold |
18,342
| – | – | 0.02% | 922 |
|
|
2019
Q3 | $1.33M | Hold |
18,342
| – | – | 0.01% | 938 |
|
|
2019
Q2 | $1.58M | Sell |
18,342
-32,166
| -64% | -$2.61M | 0.02% | 914 |
|
|
2019
Q1 | $4.08M | Buy |
50,508
+33,672
| +200% | +$2.52M | 0.01% | 938 |
|
|
2018
Q4 | $1.03M | Hold |
16,836
| – | – | 0.01% | 1007 |
|
|
2018
Q3 | $1.21M | Sell |
16,836
-2,061
| -11% | -$130K | 0.01% | 1047 |
|
|
2018
Q2 | $991K | Buy |
18,897
+2,151
| +13% | +$101K | 0.01% | 1019 |
|
|
2018
Q1 | $727K | Hold |
16,746
| – | – | 0.01% | 1156 |
|
|
2017
Q4 | $812K | Buy |
+16,746
| New | +$845K | 0.01% | 1124 |
|
Other funds holding OMCL
NAMI
MetLife Investment Management's OMCL Position: Q2 2026 in Review
MetLife Investment Management increased its Omnicell (OMCL) stake by 2.6% in Q2 2026, buying an estimated $26.8K and bringing the position to 26,636 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #1475.
MetLife Investment Management first reported a position in OMCL in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.41M in Q3 2022. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.
- MetLife Investment Management held 26,636 shares of Omnicell worth $1.11M as of Q2 2026.
- MetLife Investment Management bought 666 Omnicell shares in Q2 2026, an estimated $26.8K.
- Omnicell made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1475 holding.
- MetLife Investment Management first reported a position in Omnicell in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Omnicell position peaked at $4.41M in Q3 2022.
- 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.